Search papers, labs, and topics across Lattice.
The paper introduces SCENE, a bi-level multi-agent framework, to contextualize broad biomedical knowledge into scenario-grounded propositions by iteratively searching for relationships between general knowledge and specific datasets. SCENE converts broad knowledge into search directions, grounds them in the dataset schema, and then optimizes for concrete propositions balancing evidential strength and data support. Experiments in clinical trials and L1000 studies demonstrate that SCENE discovers specific, well-supported subgroups and identifies perturbational contexts with strong target-response matching, outperforming existing baselines.
Uncover hidden connections between broad biomedical knowledge and specific experimental data with SCENE, a framework that transforms general knowledge into testable, scenario-grounded hypotheses.
Biomedical discovery often requires connecting broad biomedical knowledge with specific experimental or clinical data. Background knowledge suggests relevant mechanisms but is usually too general to map directly onto dataset variables, while data-driven patterns can be dataset-specific and hard to interpret mechanistically. We study this missing link as knowledge contextualization: transforming broad biomedical knowledge into evidence-supported, scenario-grounded propositions that domain experts can inspect, replay, and validate. We propose SCENE, a bi-level multi-agent framework that treats knowledge contextualization as iterative search. The upper level converts broad knowledge into search directions and grounds them in the dataset schema. The lower level executes these directions through multi-objective optimization to identify concrete propositions that balance evidential strength and data support. Feedback between the two levels progressively refines the search. We evaluate SCENE in two settings: discovering patient subgroups with heterogeneous treatment benefits in clinical trial scenarios, and identifying context-specific biological responses in LINCS L1000 studies. In clinical trials, SCENE discovers specific, well-supported subgroups and outperforms existing baselines. In L1000 studies, SCENE identifies perturbational contexts with strong target-response matching and high positive rates. These results show that SCENE bridges broad knowledge and scenario-specific evidence, producing traceable, inspectable hypotheses for follow-up validation.
